Recent Advances in Head and Neck Tumor Microenvironment–Based Therapy
Head and neck squamous cell carcinomas (HNSCCs) are a group of heterogeneous
aggressive tumors affecting more than half a million patients worldwide annually. While the …
aggressive tumors affecting more than half a million patients worldwide annually. While the …
Oral sampling methods are associated with differences in immune marker concentrations
Objective To determine whether the concentration and distribution of immune markers in
paired oral samples were similar. Study Type Clinical research. Study Design Cross …
paired oral samples were similar. Study Type Clinical research. Study Design Cross …
CCL17/CCL22 Predict the Survival and Response to Immune Checkpoint Blockade Therapy of Patients with HNSCC
W Zhou, X Zhang, Y Long, X Lin, Y Zhang, Z Liu - 2021 - researchsquare.com
Background: Head and neck squamous cell carcinoma (HNSCC) was considered as an
immunosuppressive disease. Cross-talk between cancer cells and immune cells is …
immunosuppressive disease. Cross-talk between cancer cells and immune cells is …
Bioinformatics Analysis and Computational Biology Modeling of Genetic and Epigenetic Elements Dictating Chromatin Organization, Transcription Regulation, and …
J Chyr - 2020 - search.proquest.com
Cancer is the second leading cause of death worldwide with over 17 million new cases and
over 9.6 million deaths annually. Hence, it is one of the biggest research topics of our time …
over 9.6 million deaths annually. Hence, it is one of the biggest research topics of our time …
Oncogenes E6 e E7 do papilomavirus humano tipo 16 e mediadores de inflamação regulam a transição epitélio-mesenquimal em células de carcinoma de cabeça e …
ACB Stefanini - 2019 - teses.usp.br
O carcinoma epidermoide de cabeça e pescoço (HNSCC) é uma das neoplasias mais
frequentes e geralmente está associado a inflamação crônica e níveis sistêmicos de …
frequentes e geralmente está associado a inflamação crônica e níveis sistêmicos de …
[PDF][PDF] Rola układu immunologicznego w patogenezie oraz progresji płaskonabłonkowego raka głowy i szyi
N Maćkowska, A Sobecka, W Golusiński… - Letters in Oncology …, 2019 - scholar.archive.org
Płaskonabłonkowy rak głowy i szyi (HNSCC, ang. Head and Neck Squamous Cell
Carcinoma) to nowotwór wywodzący się z komórek płaskonabłonkowych błon śluzowych …
Carcinoma) to nowotwór wywodzący się z komórek płaskonabłonkowych błon śluzowych …
6 Immunotherapy
S Renjith, S Chandran - api.taylorfrancis.com
Head and neck squamous cell carcinoma (HNSCC) denotes a heterogeneous disease
entity, which comprises a variety of tumors originating in the lip/oral cavity, hypopharynx …
entity, which comprises a variety of tumors originating in the lip/oral cavity, hypopharynx …
Immunotherapy: Improving Survival, Quality of Life in Rapidly Progressing Head and Neck Cancer
S Renjith, S Chandran - Understanding Cancer Therapies, 2018 - taylorfrancis.com
Head and neck squamous cell carcinoma (HNSCC) denotes a heterogeneous disease
entity, which comprises a variety of tumors originating in the lip/oral cavity, hypopharynx …
entity, which comprises a variety of tumors originating in the lip/oral cavity, hypopharynx …
T Cell-directed Immunotherapeutic Approaches for Head and Neck Squamous Cell Carcinoma
YS Choi - Korean Journal of Head & Neck Oncology, 2017 - koreascience.kr
Despite improved treatment outcomes of locally advanced disease over the last 2 decades,
the survival of patients with recurrent and/or metastatic head and neck squamous cell …
the survival of patients with recurrent and/or metastatic head and neck squamous cell …